Researchers at Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory ...
Jul 28, 2020
0
6
Earlier this week, the BBC reported that one third of COVID-19 patients developed dangerous blood clots. While current treatments are mainly focusing on anti-viral and potentially anti-inflammatory treatments, these only ...
May 19, 2020
0
1
People with blood types A and B may have higher risks for developing dangerous blood clots compared to people who have type O blood. That's according to new research that also showed a slightly higher risk for certain types ...
Jan 23, 2020
0
1368
It's the third deadliest cardiovascular diagnosis, but doctors are still often stumped to explain why 40% of patients experience unprovoked venous thromboembolism (VTE). And after a patient has dealt with these dangerous ...
May 29, 2019
0
4
